AKT1 and metabolic dysfunction-associated steatotic liver disease: Furthermore, 5 out of these 7 pathways (Oxidative phosphorylation, Non-alcoholic fatty liver disease, Pathways in cancer, Metabolic pathways and PI3K-Akt signaling) did not have significant Odds Ratio (Odds Ratio > 1.3, adjusted p-value < .05) for any of the 9 studied diseases.